TACT study and cardiac events.
Surprisingly chelation but not high vitamin intake diminishes the recurrence rate of MAjor Cardiovascular Events.
"26.5% in the chelation group versus 30% in the placebo group
(HR 0.82, 0.69-0.99, p=0.035)"
http://www.forbes.com/sites/larryhusten/2012/11/04/nih-trial-gives-surprising-boost-to-chelation-therapy/
http://www.nutraingredients.com/Research/High-dose-vitamins-and-minerals-offer-no-benefit-for-recurrent-cardiac-events/?utm_source=Newsletter_Subject&utm_medium=email&utm_campaign=Newsletter%2BSubject&c=Cj6Zsw90Sron3Ro2kog2Tg%3D%3D
https://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&ved=0CDQQFjAA&url=http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT00044213&ei=8f9SUZilAsmr7AaZ74D4DA&usg=AFQjCNETdX87b3h4hLFZbjX5zuGH3ZdOKw&sig2=AluEMA-RM61_WeRft-SUnw&bvm=bv.44342787,d.ZGU
Inscription à :
Publier les commentaires (Atom)
Articles
Aucun commentaire:
Enregistrer un commentaire